WO2024217724 - PHARMACEUTICAL COMPOSITION COMPRISING AN ANTIMICROBIAL AGENT AND METHOD FOR THE PREPARATION THEREOF
National phase entry:
Publication Number
WO/2024/217724
Publication Date
24.10.2024
International Application No.
PCT/EP2024/025148
International Filing Date
15.04.2024
Title **
[English]
PHARMACEUTICAL COMPOSITION COMPRISING AN ANTIMICROBIAL AGENT AND METHOD FOR THE PREPARATION THEREOF
[French]
COMPOSITION PHARMACEUTIQUE COMPRENANT UN AGENT ANTIMICROBIEN ET SON PROCÉDÉ DE PRÉPARATION
Applicants **
PHARMATHEN S.A.
6, Dervenakion Str.
153 51 PALLINI ATTIKIS, GR
Inventors
KARAVAS, Evangelos
6, Dervenakion Str.
153 51 PALLINI ATTIKIS, GR
KOUTRIS, Efthymios
6, Dervenakion Str.
153 51 PALLINI ATTIKIS, GR
SAMARA, Vasiliki
6, Dervenakion Str.
153 51 PALLINI ATTIKIS, GR
KOUTRI, Ioanna
6, Dervenakion Str.
153 51 PALLINI ATTIKIS, GR
KALASKANI, Anastasia
6, Dervenakion Str.
153 51 PALLINI ATTIKIS, GR
FOUSTERIS, Manolis
6, Dervenakion Str.
153 51 PALLINI ATTIKIS, GR
DRAGANOUDI, Christina
6, Dervenakion Str.
153 51 PALLINI ATTIKIS, GR
Priority Data
20230100332
20.04.2023
GR
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 963 | |
| EPO | Filing, Examination | 3598 | |
| Japan | Filing | 597 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 2710 |
Total: 8443 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to a stable pharmaceutical formulation of solid dosage forms for oral administration comprising an antimicrobial agent such as Rifaximin or a pharmaceutical acceptable salt, derivative or polymorph thereof as the active ingredient. It also relates to an innovative process for the preparation thereof.[French]
La présente invention concerne une formulation pharmaceutique stable de formes posologiques solides pour administration orale comprenant un agent antimicrobien tel que la rifaximine ou un sel, un dérivé ou un polymorphe pharmaceutiquement acceptable de celui-ci en tant que principe actif. L'invention concerne également un procédé innovant pour la préparation de celui-ci.